RETRACTED: Amelioration of Osteoporosis by Menatetrenone in Elderly Female Parkinson's Disease Patients With Vitamin D Deficiency (Bone (2002) 31(1) (114–118) (S8756328202007834)(10.1016/S8756-3282(02)00783-4));Amelioration of osteoporosis by menatetrenone in elderly female Parkinson's disease patients with vitamin D deficiency

Bone

Volumn 31, Issue 1, 2002, Pages 114-118

  Sato, Y ^a,b,c   Honda, Y ^b   Kaji, M ^c   Asoh, T ^d   Hosokawa, K ^a   Kondo, I ^a   Satoh, K ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b Ohshima Hospital   (Japan)

^c KURUME UNIVERSITY MEDICAL CENTER   (Japan)

^d Futase Social Insurance Hospital   (Japan)

Author keywords

Fracture; Immobilization; Menatetrenone (MK 4); Osteoporosis; Parkinson's disease (PD)

Indexed keywords

CALCITRIOL; CALCIUM ION; MENATETRENONE; OSTEOCALCIN; PARATHYROID HORMONE; VITAMIN K GROUP;

AGED; ARTICLE; BIOSYNTHESIS; BLOOD LEVEL; BONE DENSITY; BONE MINERAL; CALCIUM BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; FRACTURE; HIP FRACTURE; HUMAN; HYPERCALCEMIA; KIDNEY; MAJOR CLINICAL STUDY; METACARPAL BONE; OSTEOLYSIS; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HORMONE RELEASE; PARKINSON DISEASE; RANDOMIZED CONTROLLED TRIAL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN K DEFICIENCY;

EID: 0036309437     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2017.10.006     Document Type: Erratum

References (31)

1. Why patients with Parkinson's disease fall
2. Circulating vitamin K levels in patients with fractures
3. Sequential fractures of both hips in elderly patients - A prospective study
4. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older
5. Hip fractures in patients with Parkinson's syndrome
6. Risk factors for falls as a cause of hip fracture in women
7. 1 in osteoporosis
8. Parkinsonism: Onset, progression, and mortality
9. 2 decreased in elderly women with hip fractures
10. Depressed levels of circulation menaquinones in patients with osteoporotic fractures of the spine and femoral neck
11. Fracture risk in patients with parkinsonism: A population-based study in Olmsted Country, Minnesota
12. Bone mineral density in patients with Parkinson's disease measured by dual photon absorptiometry
13. Falls and Parkinson's disease
14. 1 epoxide in human plasma with electrofluorimetric reaction detection
15. Immobilization hypercalcemia treatment with pamidronate disodium after spinal cord injury
16. Metacarpal bone mass in normal and osteoporotic Japanese women using computed X-ray densitometry
17. 2 on three dimensional trabecular microarchitecture in ovariectomized rats
18. Successful treatment of Immobilization hypercalcemia using calcitonin and etidronate
19. Clinical evaluation of menatetrenone in the treatment of involutional osteoporosis - A double-blind multicenter comparative study
20. Effects of menatetrenone on the bone and calcium metabolism in osteoporosis: A double-blind placebo-controlled study
21. Fractures after stroke
22. Evaluation of urinary hydroxypyridinium cross-link measurements as resorption markers in metabolic bone disease
23. High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease
24. 3 in Parkinson's disease
25. Effect of immobilization on vitamin D status and bone mass in chronically hospitalized disabled stroke patients
26. 2 (Menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis
27. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women
28. Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women
29. Reduced bone density of the hip in elderly patients with Parkinson's disease
30. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: The EPIDOS study
31. Role of vitamin K in bone metabolism